AxoGen, Inc. (AXGN) Stock Forecast
AXGN analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 12 analysts
- Price target
- $53.55 average of analyst targets
- Upside to target
- +54.7% from the latest close
- Next earnings
- October 28, 2026 EPS estimate $-0.03
- 52-week range
- $16.97 – $51.73
AXGN analyst ratings
12 analystsNumber of analysts at each rating.
AXGN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AXGN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.13 | $0.08 | $0.16 | $0.12 | +11.7% | 9 |
| Current fiscal year (2026) | $0.48 | $0.42 | $0.51 | $0.29 | +65.0% | 7 |
| Next fiscal year (2027) | $0.72 | $0.56 | $0.90 | $0.48 | +50.7% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AXGN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $73.2M | $72.0M | $74.1M | +21.8% | 10 |
| Current fiscal year (2026) | $285.6M | $285.0M | $286.3M | +26.8% | 7 |
| Next fiscal year (2027) | $367.4M | $354.9M | $374.6M | +28.6% | 8 |
AXGN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AXGN revenue: reported and forecast
AXGN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.14 | $0.13 | $0.13 | $0.13 | $0.13 | −7.1% | 1 up · 1 down |
| Current fiscal year (2026) | $0.49 | $0.46 | $0.46 | $0.47 | $0.48 | −2.1% | 1 up · 3 down |
| Next fiscal year (2027) | $0.72 | $0.69 | $0.68 | $0.72 | $0.72 | −0.5% | 2 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AXGN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AXGN beat in 11 of 12.
What analysts expect from AXGN
12 analysts cover AxoGen; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $53.55, 54.7% above the latest close of $34.62. Analysts expect earnings of $0.48 per share for 2026, +65.0% from a year earlier. For 2027 the average estimate is $0.72 per share on revenue of $367.4 million. AxoGen beat the EPS estimate in 11 of the last 12 quarters.
Related: AXGN income statement, AXGN key metrics, AXGN chart. See the AXGN stock overview for the latest quote and news.
AXGN forecast FAQ
What is AxoGen's price target?
The average analyst price target for AxoGen is $53.55, 54.7% above the latest close of $34.62.
Is AxoGen a buy, hold or sell?
Of 12 analysts covering AxoGen, 9 rate it a strong buy, 3 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is AxoGen's EPS forecast?
Analysts forecast $0.48 per share for 2026 (range $0.42 to $0.51); for 2027 the estimate is $0.72.
What is AxoGen's revenue forecast?
The average revenue estimate for 2026 is $285.6 million, growth of 26.8%; for 2027 it is $367.4 million.
When does AxoGen report earnings?
AxoGen is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 before the market opens; the EPS estimate is $-0.03.
Does AxoGen usually beat earnings estimates?
AxoGen reported EPS at or above the analyst estimate in 11 of the last 12 quarters.